These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17942801)

  • 1. Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
    Tsukamoto T; Morita K; Naya M; Inubushi M; Katoh C; Nishijima K; Kuge Y; Okamoto H; Tsutsui H; Tamaki N
    J Nucl Med; 2007 Nov; 48(11):1777-82. PubMed ID: 17942801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
    Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M
    J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
    Matsunari I; Aoki H; Nomura Y; Takeda N; Chen WP; Taki J; Nakajima K; Nekolla SG; Kinuya S; Kajinami K
    Circ Cardiovasc Imaging; 2010 Sep; 3(5):595-603. PubMed ID: 20534790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine 123-metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction.
    Yuyama R; Yuasa F; Hikosaka M; Mimura J; Kawamura A; Hatada K; Motohiro M; Iwasaki M; Sugiura T; Iwasaka T
    Clin Physiol Funct Imaging; 2005 Jan; 25(1):34-9. PubMed ID: 15659078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
    Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M
    J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
    Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
    J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
    Chizzola PR; Gonçalves de Freitas HF; Marinho NV; Mansur JA; Meneghetti JC; Bocchi EA
    Int J Cardiol; 2006 Jan; 106(1):29-34. PubMed ID: 16321662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Koyama Y; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Okada A; Takahashi K; Kubota I
    Ann Nucl Med; 2005 Oct; 19(7):535-40. PubMed ID: 16363617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause.
    Imamura Y; Ando H; Mitsuoka W; Egashira S; Masaki H; Ashihara T; Fukuyama T
    J Am Coll Cardiol; 1995 Dec; 26(7):1594-9. PubMed ID: 7594091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H
    J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
    Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
    J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.